BioAge Labs (BIOA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BIOA BioAge Labs

Watchlist

4.180
-0.170-3.91%

Close Feb 25 16:00 ET

149.85MMarket Cap-2.02P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference
GlobeNewswireFeb 20 16:30 ET
Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch
Analysts NotebookFeb 13 06:50 ET
Citi Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7
Moomoo NewsJan 29 07:31 ET · Ratings
Morgan Stanley Downgrades BioAge Labs(BIOA.US) to Sell Rating, Cuts Target Price to $5
Moomoo NewsJan 29 07:31 ET · Ratings
BioAge Labs Faces Sell Rating Amid Safety Concerns and Uncertain Prospects
TipRanksJan 29 07:16 ET · Ratings
BioAge Labs: Strategic Shifts and Developmental Progress Support Hold Rating Amidst Inherent Risks
TipRanksJan 29 06:46 ET · Ratings

Comments

Teddy123

Feb 20 03:44

BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing

$BioAge Labs (BIOA.US)$
Alzheimer's Drug Deal: How BioArctic's $1.3B Bristol Myers Agreement Could Transform Treatment

Sean Parker

Feb 20 00:39

BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing

$BioAge Labs (BIOA.US)$
BioArctic AB announced the completion of its global license agreement with Bristol Myers Squibb after receiving U.S. Federal Trade Commission clearance. The agreement, initially announced on December 19, 2024, grants Bristol Myers Squibb worldwide development and commercialization rights for BAN1503 and BAN2803, part ...

Teddy123

Feb 18 03:56

Leqembi® sales reaches €200 million - first sales milestone achieved

$BioAge Labs (BIOA.US)$
Milestone Achievement: Alzheimer's Breakthrough Leqembi Reaches €200M Sales, Triggering Major Payout

Analysts Notebook

Feb 13 05:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...

113

277

103753999

Feb 5 09:43

$BioAge Labs (BIOA.US)$ no volume

BIOA BioAge Labs

Trade Overview

Capital Trend

News

Comments

Trending Stocks